These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1188917)

  • 1. Combined cancer chemotherapy with cyclophoshamide and an inducer of microsomal drug-metabolizing enzymes (cytochrome P-450) in tumor-bearing rats.
    Oira S; Maezawa S; Irinoda Y; Watanabe K; Kitada K
    Tohoku J Exp Med; 1975 Aug; 116(4):341-50. PubMed ID: 1188917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coenzyme Q10 in cancer chemotherapy--experimental studies on augmentation of the effects of masked compounds, especially in the combined chemotherapy with immunopotentiators].
    Kokawa T; Shiota K; Oda K; Okubo S; Okamoto Y; Okubo H
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):768-74. PubMed ID: 6881995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inducer of liver drug-metabolizing enzyme on blood level of active metabolites of cyclophosphamide in rats and in cancer patients.
    Maezawa S; Ohira S; Sakuma M; Matsuoka S; Wakui A; Saito T
    Tohoku J Exp Med; 1981 May; 134(1):45-53. PubMed ID: 7314093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased lifespan by the sequential treatment with improsulfan and cyclophosphamide in rats bearing Yoshida ascites sarcoma.
    Okumoto T; Imamura H
    Chem Pharm Bull (Tokyo); 1976 Aug; 24(8):1913-6. PubMed ID: 184972
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased antitumor activity of cyclophosphamide (Endoxan) following pretreatment with inducer of drug-metabolizing enzymes (cytochrome P-450).
    Oira S; Maezawa S; Irinoda Y; Watanabe K; Kitada K
    Tohoku J Exp Med; 1974 Sep; 114(1):55-60. PubMed ID: 4432244
    [No Abstract]   [Full Text] [Related]  

  • 6. Ifosfamide in experimental tumor systems.
    Goldin A
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):14-23. PubMed ID: 6761864
    [No Abstract]   [Full Text] [Related]  

  • 7. The timing of cyclophosphamide therapy in tumor-bearing rats affects the resistance to tumor challenge in survivors.
    Marusić M; Allegretti N; Culo F
    Experientia; 1978 Oct; 34(10):1355-6. PubMed ID: 738420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the anti-cancer drug ifosphamide by rat liver microsomal P450 enzymes.
    Weber GF; Waxman DJ
    Biochem Pharmacol; 1993 Apr; 45(8):1685-94. PubMed ID: 8484807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the effect of cyclophosphamide on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Bhide S; Habs M; Reinhold H; Schmähl D
    Arzneimittelforschung; 1979; 29(3):477-9. PubMed ID: 582732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of parallelism between microsomal enzyme induction and phenobarbital-induced hypercholeresis in the rat.
    Chivrac D; Dumont M; Erlinger S
    Digestion; 1978; 17(6):516-25. PubMed ID: 710737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental animal studies on the regional perfusion of tumors of the extremities].
    Brock N; Niekamp T
    Arzneimittelforschung; 1968 Jan; 18(1):1-7. PubMed ID: 5754938
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
    Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
    Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modification of the mutagenic effect of cyclophosphamide after long-term induction of the microsomal monooxygenase system].
    Sycheva LP; Burmantova NP; Zhurkov VS
    Gig Sanit; 1989 Mar; (3):82-4. PubMed ID: 2744518
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor activity of improsulfan by the fractionated dose schedule on rat ascites tumors.
    Okumoto T; Imamura H
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2668-72. PubMed ID: 189948
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of loratadine as an inducer of liver microsomal cytochrome P450 in rats and mice.
    Parkinson A; Clement RP; Casciano CN; Cayen MN
    Biochem Pharmacol; 1992 May; 43(10):2169-80. PubMed ID: 1534660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of phenobarbital and its hydroxylated metabolites on drug-metabolizing enzymes during ontogenesis.
    Cresteil T; Mahu JL; Beaune P; Columelli S; Leroux JP
    Pediatr Pharmacol (New York); 1981; 1(4):331-40. PubMed ID: 6810295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-dose phenobarbital on hepatic microsomal UDP-glucuronyl transferase activity.
    Tavoloni N; Wittman R; Jones MJ; Berk PD
    Biochem Pharmacol; 1983 Jul; 32(14):2143-7. PubMed ID: 6409115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased antitumour activity of chlorambucil following pretreatment with inducers of drug-metabolizing enzymes.
    Hill BT; Douglas ID; Grover PL
    Biochem Pharmacol; 1973 May; 22(9):1083-9. PubMed ID: 4695667
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term effects of phenobarbital on rat liver microsomal drug-metabolizing enzymes and heme-metabolizing enzyme.
    Kurata N; Yoshida T; Kuroiwa Y; Masuko T; Hashimoto Y
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):161-79. PubMed ID: 2587838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.